Gottschalk, Michaela, Kümpfel, Tania, Flachenecker, Peter et al. · Archives of neurology · 2005 · DOI
This study looked at fatigue in multiple sclerosis (MS) patients and examined whether their stress hormone system (HPA axis) might be involved. Researchers tested 31 MS patients using three different fatigue questionnaires and a special hormone test. They found that MS patients with severe fatigue had higher levels of a stress hormone called ACTH compared to MS patients without fatigue.
This study is relevant to ME/CFS research because it identifies a potential neuroendocrine mechanism for fatigue in another chronic disease, providing a comparative framework. The finding of HPA axis hyperactivity in MS fatigue (contrasting with CFS hypoactivity) highlights that fatigue in different conditions may have distinct biological underpinnings, which could inform targeted therapeutic approaches for ME/CFS.
This study does not establish causation—elevated ACTH may be a consequence rather than a cause of fatigue. The study is in MS patients, not ME/CFS patients, so findings may not directly apply to ME/CFS populations. The small sample size and lack of healthy control group limit generalizability of the HPA axis findings.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →